The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Grist, Ashley Alexander
    Pharmaceutical Executive born in September 1965
    Individual (7 offsprings)
    Officer
    2019-04-19 ~ now
    OF - director → CIF 0
  • 2
    Lem, Simon Kempin
    Commercial Manager born in February 1973
    Individual (4 offsprings)
    Officer
    2012-06-29 ~ now
    OF - director → CIF 0
  • 3
    INTERCEDE 1083 LIMITED - 1994-08-12
    2, Kingdom Street, London, England
    Corporate (4 parents, 1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 9
  • 1
    Emmens, Matthew William
    Ceo Of Vertex Pharmaceuticals Incorporated born in June 1951
    Individual
    Officer
    2011-05-26 ~ 2012-05-22
    OF - director → CIF 0
  • 2
    Bedson, Simon David
    General Manager born in August 1962
    Individual (1 offspring)
    Officer
    2011-11-16 ~ 2018-10-15
    OF - director → CIF 0
  • 3
    Wysenski, Nancy
    Chief Commercial Officer born in June 1957
    Individual
    Officer
    2011-05-26 ~ 2012-06-15
    OF - director → CIF 0
  • 4
    Bellandi, Michele
    Pharmaceutical Executive born in August 1967
    Individual
    Officer
    2018-10-15 ~ 2019-04-19
    OF - director → CIF 0
  • 5
    Leiden, Jeffrey Marc
    President & Ceo born in October 1955
    Individual
    Officer
    2012-05-22 ~ 2012-05-22
    OF - director → CIF 0
  • 6
    Smith, Ian Frederick
    Cfo Of Vertex Pharmaceuticals Incorporated born in January 1966
    Individual
    Officer
    2011-05-26 ~ 2019-01-23
    OF - director → CIF 0
  • 7
    Yuill, William George Henry
    Chartered Secretary born in September 1961
    Individual (61 offsprings)
    Officer
    2011-05-23 ~ 2011-05-26
    OF - director → CIF 0
  • 8
    Holmlund, Klas Alexander
    Pharmaceutical Executive born in July 1977
    Individual
    Officer
    2019-04-19 ~ 2021-12-03
    OF - director → CIF 0
  • 9
    CMS (NOMINEES) LIMITED - now
    MITRE HOUSE NOMINEES LIMITED - 2013-09-19
    Mitre House, 160 Aldersgate Street, London, United Kingdom
    Corporate (4 parents, 177 offsprings)
    Officer
    2011-05-23 ~ 2011-05-26
    PE - director → CIF 0
    PE - director → CIF 0
    2011-05-23 ~ 2024-05-31
    PE - secretary → CIF 0
    PE - secretary → CIF 0
parent relation
Company in focus

VERTEX PHARMACEUTICALS (U.K.) LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering

  • VERTEX PHARMACEUTICALS (U.K.) LIMITED
    Info
    Registered number 07643914
    Level 9, Paddington Central, 2 Kingdom Street, London W2 6BD
    Private Limited Company incorporated on 2011-05-23 (14 years). The company status is Active.
    The last date of confirmation statement was made at 2024-05-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.